Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

What is Life Sciences Consulting? A Comprehensive Guide

Jun 15, 2025

Understanding Life Sciences Consulting

The term "Life Sciences Consulting" might seem complex at first glance, but it essentially refers to specialized advisory services provided to companies within the life sciences sector. This sector includes pharmaceuticals, biotechnology, medical devices, and other health-related industries. Consultants in this field help these companies navigate challenges, optimize their operations, and achieve strategic goals.

life sciences consulting

The Role of Life Sciences Consultants

Life sciences consultants play a crucial role in the industry by offering expert guidance on a wide range of issues. These can include regulatory compliance, market access strategies, research and development (R&D) optimization, and digital transformation. Their expertise helps companies improve efficiency and ensure they meet industry standards and regulations.

Consultants often work with multidisciplinary teams to address complex challenges. They provide insights that can lead to innovative solutions, helping companies stay competitive in a rapidly evolving market. This support is vital for companies aiming to bring new products to market successfully.

Key Areas of Focus in Life Sciences Consulting

One of the primary areas of focus for life sciences consultants is regulatory compliance. Navigating the intricate web of global regulations requires specialized knowledge, and consultants help companies adhere to these standards to avoid costly penalties and delays.

regulatory compliance

Market access is another critical area. Consultants assist in developing strategies to ensure that products can enter and succeed in target markets. This involves understanding the competitive landscape, pricing strategies, and reimbursement processes. Effective market access strategies are essential for maximizing a product's commercial potential.

Research and Development Optimization

R&D is at the heart of the life sciences industry, driving innovation and product development. Consultants help companies streamline their R&D processes to reduce costs and time-to-market while maintaining high-quality standards. They also offer insights into emerging technologies and trends, ensuring that R&D efforts align with future industry needs.

research development

Embracing Digital Transformation

The digital transformation is reshaping the life sciences industry, offering opportunities for increased efficiency and innovation. Consultants guide companies in adopting digital tools and technologies, such as artificial intelligence, data analytics, and telehealth solutions. These advancements can lead to improved patient outcomes and more efficient operations.

Life sciences consulting firms assist in integrating digital solutions into existing infrastructures, ensuring seamless transitions and optimizing value from technological investments. They help create strategies that leverage digital tools to enhance patient engagement and streamline clinical trials.

Conclusion: The Value of Life Sciences Consulting

In conclusion, life sciences consulting provides invaluable support to companies navigating the complexities of the healthcare landscape. By focusing on areas like regulatory compliance, market access, R&D optimization, and digital transformation, consultants empower organizations to achieve their strategic objectives more effectively.

healthcare strategy

As the life sciences sector continues to evolve, the role of consultants will remain essential in driving innovation and growth. Companies that leverage the expertise of life sciences consultants can better position themselves to succeed in an increasingly competitive market.

  • Regulatory Compliance
  • Market Access
  • R&D Optimization
  • Digital Transformation